Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kivisto, KT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 99 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wen, X; Wang, JS; Kivisto, KT; Neuvonen, PJ; Backman, JT
      In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P4502C9 (CYP2C9)

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    2. Desta, Z; Kivisto, KT; Lilja, JJ; Backman, JT; Soukhova, N; Neuvonen, PJ; Flockhart, DA
      Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juice

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    3. Wen, X; Wang, JS; Backman, JT; Kivisto, KT; Neuvonen, PJ
      Gemfibrozil is a potent inhibitor of human cytochrome P4502C9

      DRUG METABOLISM AND DISPOSITION
    4. Villikka, K; Varis, T; Backman, JT; Neuvonen, PJ; Kivisto, KT
      Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    5. Kivisto, KT; Wang, JS; Backman, JT; Nyman, L; Taavitsainen, P; Anttila, M; Neuvonen, PJ
      Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    6. Niemi, M; Neuvonen, PJ; Kivisto, KT
      Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    7. Lapatto-Reiniluoto, O; Kivisto, KT; Neuvonen, PJ
      Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    8. Niemi, M; Neuvonen, PJ; Kivisto, KT
      The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    9. Niemi, M; Backman, JT; Neuvonen, M; Neuvonen, PJ; Kivisto, KT
      Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    10. Kyrklund, C; Backman, JT; Kivisto, KT; Neuvonen, M; Laitila, J; Neuvonen, PJ
      Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    11. Niemi, M; Backman, JT; Neuvonen, M; Laitila, J; Neuvonen, PJ; Kivisto, KT
      Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    12. Niemi, M; Kivisto, KT; Backman, JT; Neuvonen, PJ
      Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    13. Palovaara, S; Kivisto, KT; Tapanainen, P; Manninen, P; Neuvonen, PJ; Laine, K
      Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1 '-hydroxylation

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    14. Lapatto-Reiniluoto, O; Kivisto, KT; Neuvonen, PJ
      Gastric decontamination performed 5 min after the ingestion of temazepam, verapamil and moclobemide: charcoal is superior to lavage

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    15. Pohjola-Sintonen, S; Kivisto, KT; Vuori, E; Lapatto-Reiniluoto, O; Tiula, E; Neuvonen, PJ
      Identification of drugs ingested in acute poisoning: Correlation of patient history with drug analyses

      THERAPEUTIC DRUG MONITORING
    16. Wang, JS; Backman, JT; Taavitsainen, P; Neuvonen, PJ; Kivisto, KT
      Involvement of CYP1A2 and CYP3A4 in lidocaine N-deethylation and 3-hydroxylation in humans

      DRUG METABOLISM AND DISPOSITION
    17. Wang, JS; Backman, JT; Kivisto, KT; Neuvonen, PJ
      Effects of metronidazole on midazolam metabolism in vitro and in vivo

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    18. Varis, T; Kivisto, KT; Neuvonen, PJ
      Grapefruit juice can increase the plasma concentrations of oral methylprednisolone

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    19. Lilja, JJ; Kivisto, KT; Backman, JT; Neuvonen, PJ
      Effect of grapefruit juice dose on grapefruit juice-triazolam interaction:repeated consumption prolongs triazolam half-life

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    20. Lapatto-Reiniluoto, O; Kivisto, KT; Neuvonen, PJ
      Efficacy of activated charcoal versus gastric lavage half an hour after ingestion of moclobemide, temazepam, and verapamil

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    21. Kantola, T; Backman, JT; Niemi, M; Kivisto, KT; Neuvonen, PJ
      Effect of fluconazole on plasma fluvastatin and pravastatin concentrations

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    22. Varis, T; Kivisto, KT; Neuvonen, PJ
      The effect of itraconazole on the pharmacokinetics and pharmacodynamics oforal prednisolone

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    23. Kyrklund, C; Backman, JT; Kivisto, KT; Neuvonen, M; Laitila, J; Neuvonen, PJ
      Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    24. Varis, T; Kivisto, KT; Backman, JT; Neuvonen, PJ
      The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    25. Niemi, M; Backman, JT; Neuvonen, M; Neuvonen, PJ; Kivisto, KT
      Rifampin decreases the plasma concentrations and effects of repaglinide

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    26. Lilja, JJ; Kivisto, KT; Neuvonen, PJ
      Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    27. Backman, JT; Kyrklund, C; Kivisto, KT; Wang, JS; Neuvonen, PJ
      Plasma concentrations of active simvastatin acid are increased by gemfibrozil

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    28. Backman, JT; Maenpaa, J; Belle, DJ; Wrighton, SA; Kivisto, KT; Neuvonen, PJ
      Lack of correlation between in vitro and in vivo studies on the effects oftangeretin and tangerine juice on midazolam hydroxylation

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    29. Varis, T; Backman, JT; Kivisto, KT; Neuvonen, PJ
      Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    30. Wang, JS; Backman, JT; Wen, X; Taavitsainen, P; Neuvonen, PJ; Kivisto, KT
      Fluvoxamine is a more potent inhibitor of lidocaine metabolism than ketoconazole and erythromycin in vitro

      PHARMACOLOGY & TOXICOLOGY
    31. Seppala, NH; Leinonen, EVJ; Lehtonen, ML; Kivisto, KT
      Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients

      PHARMACOLOGY & TOXICOLOGY
    32. Wang, JS; Wen, X; Backman, JT; Taavitsainen, P; Neuvonen, PJ; Kivisto, KT
      Midazolam alpha-hydroxylation by human liver microsomes in vitro: Inhibition by calcium channel blockers, itraconazole and ketoconazole

      PHARMACOLOGY & TOXICOLOGY
    33. Varis, T; Kivisto, KT; Backman, JT; Neuvonen, PJ
      Itraconazole decreases the clearance and enhances the effects of intravenously administered methylprednisolone in healthy volunteers

      PHARMACOLOGY & TOXICOLOGY
    34. Lamberg, TS; Kivisto, KT; Neuvonen, PJ
      Lack of effect of terfenadine on the pharmacokinetics of the CYP3A4 substrate buspirone

      PHARMACOLOGY & TOXICOLOGY
    35. Kivisto, KT; Lamberg, TS; Neuvonen, PJ
      Interactions of buspirone with itraconazole and rifampicin: Effects on thepharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone

      PHARMACOLOGY & TOXICOLOGY
    36. Lapatto-Reiniluoto, O; Kivisto, KT; Neuvonen, PJ
      Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    37. Kivisto, KT; Laitila, J; Martensson, K; Neuvonen, PJ
      Determination of buspirone and 1-(2-pyrimidinyl)-piperazine (1-PP) in human plasma by capillary gas chromatography

      THERAPEUTIC DRUG MONITORING
    38. Fritz, P; Sperker, B; Murdter, TE; Spath, M; Schwarzmann, P; Kroemer, HK; Eichelbaum, M; Kivisto, KT
      Quantitative immunohistochemical analysis of the glutathione S-transferaseGSTM1: in situ phenotyping in archival material

      XENOBIOTICA
    39. Kantola, T; Kivisto, KT; Neuvonen, PJ
      Effect of itraconazole on cerivastatin pharmacokinetics

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    40. Villikka, K; Kivisto, KT; Maenpaa, H; Joensuu, H; Neuvonen, PJ
      Cytochrome P450-inducing antiepileptics increase the clearance of vincristine in patients with brain tumors

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    41. Kivisto, KT; Lilja, TJ; Backman, JT; Neuvonen, PJ
      Repeated consumption of grapefruit juice considerably increases plasma concentrations of cisapride

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    42. Backman, JT; Wang, JS; Wen, X; Kivisto, KT; Neuvonen, PJ
      Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    43. Lilja, JJ; Kivisto, KT; Neuvonen, PJ
      Grapefruit juice increases serum concentrations of atorvastatin and has noeffect on pravastatin

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    44. Neuvonen, PJ; Kantola, T; Kivisto, KT
      Calcium channel blocker-simvastatin interaction - Reply

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    45. Villikka, K; Kivisto, KT; Neuvonen, PJ
      The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    46. LAPATTOREINILUOTO O; KIVISTO KT; POHJOLASINTONEN S; LUOMANMAKI K; NEUVONEN PJ
      A PROSPECTIVE-STUDY OF ACUTE POISONINGS IN FINNISH HOSPITAL PATIENTS

      Human & experimental toxicology
    47. VILLIKKA K; KIVISTO KT; NEUVONEN PJ
      THE EFFECT OF DEXAMETHASONE ON THE PHARMACOKINETICS OF TRIAZOLAM

      Pharmacology & toxicology
    48. KIVISTO KT; KANTOLA T; NEUVONEN PJ
      DIFFERENT EFFECTS OF ITRACONAZOLE ON THE PHARMACOKINETICS OF FLUVASTATIN AND LOVASTATIN

      British journal of clinical pharmacology
    49. LAMBERG TS; KIVISTO KT; NEUVONEN PJ
      CONCENTRATIONS AND EFFECTS OF BUSPIRONE ARE CONSIDERABLY REDUCED BY RIFAMPICIN

      British journal of clinical pharmacology
    50. LUURILA H; KIVISTO KT; NEUVONEN PJ
      EFFECT OF ITRACONAZOLE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ZOLPIDEM

      European Journal of Clinical Pharmacology
    51. BACKMAN JT; KIVISTO KT; OLKKOLA KT; NEUVONEN PJ
      THE AREA UNDER THE PLASMA CONCENTRATION-TIME CURVE FOR ORAL MIDAZOLAMIS 400-FOLD LARGER DURING TREATMENT WITH ITRACONAZOLE THAN WITH RIFAMPICIN

      European Journal of Clinical Pharmacology
    52. Lamberg, TS; Kivisto, KT; Laitila, J; Martensson, K; Neuvonen, PJ
      The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspirone

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    53. VARIS T; KAUKONEN KM; KIVISTO KT; NEUVONEN PJ
      PLASMA METHYLPREDNISOLONE CONCENTRATIONS ARE CONSIDERABLY INCREASED BY ITRACONAZOLE

      Naunyn-Schmiedeberg's archives of pharmacology
    54. VILLIKKA K; KIVISTO KT; NYMAN L; ANTTILA M; NEUVONEN PJ
      RIFAMPICIN GREATLY REDUCES PLASMA-CONCENTRATIONS OF TAMOXIFEN

      Naunyn-Schmiedeberg's archives of pharmacology
    55. LILJA JJ; KIVISTO KT; NEUVONEN PJ
      GRAPEFRUIT JUICE-SIMVASTATIN INTERACTION - EFFECT ON SERUM CONCENTRATIONS OF SIMVASTATIN, SIMVASTATIN ACID, AND HMG-COA REDUCTASE INHIBITORS

      Clinical pharmacology and therapeutics
    56. VARIS T; KAUKONEN KM; KIVISTO KT; NEUVONEN PJ
      PLASMA-CONCENTRATIONS AND EFFECTS OF ORAL METHYLPREDNISOLONE ARE CONSIDERABLY INCREASED BY ITRACONAZOLE

      Clinical pharmacology and therapeutics
    57. KANTOLA T; KIVISTO KT; NEUVONEN PJ
      ERYTHROMYCIN AND VERAPAMIL CONSIDERABLY INCREASE SERUM SIMVASTATIN AND SIMVASTATIN ACID CONCENTRATIONS

      Clinical pharmacology and therapeutics
    58. KANTOLA T; KIVISTO KT; NEUVONEN PJ
      EFFECT OF ITRACONAZOLE ON THE PHARMACOKINETICS OF ATORVASTATIN

      Clinical pharmacology and therapeutics
    59. LAMBERG TS; KIVISTO KT; NEUVONEN PJ
      EFFECTS OF VERAPAMIL AND DILTIAZEM ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF BUSPIRONE

      Clinical pharmacology and therapeutics
    60. KANTOLA T; KIVISTO KT; NEUVONEN PJ
      GRAPEFRUIT JUICE GREATLY INCREASES SERUM CONCENTRATIONS OF LOVASTATINAND LOVASTATIN ACID

      Clinical pharmacology and therapeutics
    61. NEUVONEN PJ; KANTOLA T; KIVISTO KT
      SIMVASTATIN BUT NOT PRAVASTATIN IS VERY SUSCEPTIBLE TO INTERACTION WITH THE CYP3A4 INHIBITOR ITRACONAZOLE

      Clinical pharmacology and therapeutics
    62. NEUVONEN PJ; KANTOLA T; KIVISTO KT
      GRAPEFRUIT JUICE GREATLY INCREASES SERUM LOVASTATIN AND LOVASTATIN ACID

      Clinical pharmacology and therapeutics
    63. KIVISTO KT; LAMBERG TS; NEUVONEN PJ
      VERAPAMIL AND DILTIAZEM INCREASE PLASMA BUSPIRONE CONCENTRATIONS

      Clinical pharmacology and therapeutics
    64. Kivisto, KT; Villikka, K; Nyman, L; Anttila, M; Neuvonen, PJ
      Tamoxifen and toremifene concentrations in plasma are greatly decreased byrifampin

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    65. Lilja, JJ; Kivisto, KT; Backman, JT; Lamberg, TS; Neuvonen, PJ
      Grapefruit juice substantially increases plasma concentrations of buspirone

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    66. KIVISTO KT; NEUVONEN PJ; TARSSANEN L
      PHARMACOKINETICS OF VERAPAMIL IN OVERDOSE

      Human & experimental toxicology
    67. KIVISTO KT; GRIESE KU; STUVEN T; FRITZ P; FRIEDEL G; KROEMER HK; ZANGER UM
      ANALYSIS OF CYP2D6 EXPRESSION IN HUMAN LUNG - IMPLICATIONS FOR THE ASSOCIATION BETWEEN CYP2D6 ACTIVITY AND SUSCEPTIBILITY TO LUNG-CANCER

      Pharmacogenetics
    68. LAPATTO O; KIVISTO KT; SALORINNE Y
      THE EFFECTS OF GLYCERYL TRINITRATE AND NICOTINIC-ACID OINTMENTS DURING COLD-EXPOSURE

      Pharmacology & toxicology
    69. LAINE K; KIVISTO KT; NEUVONEN PJ
      EFFECT OF DELAYED ADMINISTRATION OF ACTIVATED-CHARCOAL ON THE ABSORPTION OF CONVENTIONAL AND SLOW-RELEASE VERAPAMIL

      Journal of toxicology. Clinical toxicology
    70. VILLIKKA K; KIVISTO KT; LAMBERG TS; KANTOLA T; NEUVONEN PJ
      CONCENTRATIONS AND EFFECTS OF ZOPICLONE ARE GREATLY REDUCED BY RIFAMPICIN

      British journal of clinical pharmacology
    71. LAINE K; KIVISTO KT; LAAKSO I; NEUVONEN PJ
      PREVENTION OF AMLODIPINE ABSORPTION BY ACTIVATED-CHARCOAL - EFFECT OFDELAY IN CHARCOAL ADMINISTRATION

      British journal of clinical pharmacology
    72. LUOMANMAKI K; TIULA E; KIVISTO KT; NEUVONEN PJ
      PHARMACOKINETICS OF DILTIAZEM IN MASSIVE OVERDOSE

      Therapeutic drug monitoring
    73. LAINE K; KIVISTO KT; OJALAKARLSSON P; NEUVONEN PJ
      EFFECT OF ACTIVATED-CHARCOAL ON THE PHARMACOKINETICS OF PHOLCODINE, WITH SPECIAL REFERENCE TO DELAYED CHARCOAL INGESTION

      Therapeutic drug monitoring
    74. KIVISTO KT; KROEMER HK
      USE OF PROBE DRUGS AS PREDICTORS OF DRUG-METABOLISM IN HUMANS

      Journal of clinical pharmacology
    75. MURDTER TE; SPERKER B; FRIEDEL G; LINDER A; KIVISTO KT; MCCLELLAN M; FRITZ P; BOSSLET K; KROEMER HK
      BIOACTIVATION OF A GLUCURONYL-SPACER-DOXORUBICIN PRODRUG BY BETA-GLUCURONIDASE - A STUDY USING THE HUMAN LUNG PERFUSION MODEL

      Naunyn-Schmiedeberg's archives of pharmacology
    76. NEUVONEN PJ; KANTOLA T; KIVISTO KT
      EFFECT OF ITRACONAZOLE ON SERUM CONCENTRATIONS OF SIMVASTATIN AND PRAVASTATIN

      Atherosclerosis
    77. VILLIKKA K; KIVISTO KT; LUURILA H; NEUVONEN PJ
      RIFAMPIN REDUCES PLASMA-CONCENTRATIONS AND EFFECTS OF ZOLPIDEM

      Clinical pharmacology and therapeutics
    78. KIVISTO KT; LAMBERG TS; KANTOLA T; NEUVONEN PJ
      PLASMA BUSPIRONE CONCENTRATIONS ARE GREATLY INCREASED BY ERYTHROMYCINAND ITRACONAZOLE

      Clinical pharmacology and therapeutics
    79. VILLIKKA K; KIVISTO KT; BACKMAN JT; OLKKOLA KT; NEUVONEN PJ
      TRIAZOLAM IS INEFFECTIVE IN PATIENTS TAKING RIFAMPIN

      Clinical pharmacology and therapeutics
    80. MURDTER TE; SPERKER B; KIVISTO KT; MCCLELLAN M; FRITZ P; FRIEDEL G; LINDER A; BOSSLET K; TOOMES H; DIERKESMANN R; KROEMER HK
      ENHANCED UPTAKE OF DOXORUBICIN INTO BRONCHIAL-CARCINOMA - BETA-GLUCURONIDASE MEDIATES RELEASE OF DOXORUBICIN FROM A GLUCURONIDE PRODRUG (HMR-1826) AT THE TUMOR SITE

      Cancer research
    81. LAINE K; KIVISTO KT; PELTTARI S; NEUVONEN PJ
      THE EFFECT OF ACTIVATED-CHARCOAL ON THE ABSORPTION OF FLUOXETINE, WITH SPECIAL REFERENCE TO DELAYED CHARCOAL ADMINISTRATION

      Pharmacology & toxicology
    82. KIVISTO KT; BOOKJANS G; FROMM MF; GRIESE EU; MUNZEL P; KROEMER HK
      EXPRESSION OF CYP3A4, CYP3A5 AND CYP3A7 IN HUMAN DUODENAL TISSUE

      British journal of clinical pharmacology
    83. LINDER A; FRIEDEL G; FRITZ P; KIVISTO KT; MCCLELLAN M; TOOMES H
      THE EX-VIVO ISOLATED, PERFUSED HUMAN LUNG MODEL - DESCRIPTION AND POTENTIAL APPLICATIONS

      The thoracic and cardiovascular surgeon
    84. KIVISTO KT; GRIESE EU; FRITZ P; LINDER A; HAKKOLA J; RAUNIO H; BEAUNE P; KROEMER HK
      EXPRESSION OF CYTOCHROME-P-450 3A ENZYMES IN HUMAN LUNG - A COMBINED RT-PCR AND IMMUNOHISTOCHEMICAL ANALYSIS OF NORMAL TISSUE AND LUNG-TUMORS

      Naunyn-Schmiedeberg's archives of pharmacology
    85. LEHTO P; LAINE K; KIVISTO KT; NEUVONEN PJ
      THE EFFECT OF PH ON THE IN-VITRO DISSOLUTION OF 3 2ND-GENERATION SULFONYLUREA PREPARATIONS - MECHANISM OF ANTACID-SULFONYLUREA INTERACTION

      Journal of Pharmacy and Pharmacology
    86. KIVISTO KT; FRITZ P; LINDER A; FRIEDEL G; BEAUNE P; KROEMER HK
      IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 3A IN HUMAN PULMONARY CARCINOMAS AND NORMAL BRONCHIAL TISSUE

      HISTOCHEMISTRY AND CELL BIOLOGY
    87. KIVISTO KT; LINDER A; FRIEDEL G; BEAUNE P; BELLOC C; KROEMER HK; FRITZ P
      IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOCHROME-P450 2E1 IN HUMAN PULMONARY-CARCINOMA AND NORMAL BRONCHIAL TISSUE

      Virchows Archiv
    88. KIVISTO KT; KROEMER HK; EICHELBAUM M
      THE ROLE OF HUMAN CYTOCHROME-P450 ENZYMES IN THE METABOLISM OF ANTICANCER AGENTS - IMPLICATIONS FOR DRUG-INTERACTIONS

      British journal of clinical pharmacology
    89. LEHTO P; KIVISTO KT
      EFFECTS OF MILK AND FOOD ON THE ABSORPTION OF ENOXACIN

      British journal of clinical pharmacology
    90. LAINE K; KIVISTO KT; NEUVONEN PJ
      THE EFFECT OF ACTIVATED-CHARCOAL ON THE ABSORPTION AND ELIMINATION OFASTEMIZOLE

      Human & experimental toxicology
    91. ROIVAS L; KIVISTO KT; NEUVONEN PJ
      DESORPTION OF FUROSEMIDE FROM CHARCOAL IN-VITRO AND IN MAN

      International journal of clinical pharmacology and therapeutics
    92. NEUVONEN PJ; KIVISTO KT
      ENHANCEMENT OF DRUG ABSORPTION BY ANTACIDS - AN UNRECOGNIZED DRUG-INTERACTION

      Clinical pharmacokinetics
    93. KIVISTO KT; NEUVONEN PJ; KLOTZ U
      INHIBITION OF TERFENADINE METABOLISM - PHARMACOKINETIC AND PHARMACODYNAMIC CONSEQUENCES

      Clinical pharmacokinetics
    94. LEHTO P; KIVISTO KT; NEUVONEN PJ
      THE EFFECT OF FERROUS SULFATE ON THE ABSORPTION OF NORFLOXACIN, CIPROFLOXACIN AND OFLOXACIN

      British journal of clinical pharmacology
    95. LEHTO P; KIVISTO KT
      EFFECT OF SUCRALFATE ON ABSORPTION OF NORFLOXACIN AND OFLOXACIN

      Antimicrobial agents and chemotherapy
    96. KIVISTO KT; KALLIO A; NEUVONEN PJ
      PHARMACOKINETICS AND PHARMACODYNAMICS OF TRANSDERMAL DEXMEDETOMIDINE

      European Journal of Clinical Pharmacology
    97. LEHTO P; KIVISTO KT
      DIFFERENT EFFECTS OF PRODUCTS CONTAINING METAL-IONS ON THE ABSORPTIONOF LOMEFLOXACIN

      Clinical pharmacology and therapeutics
    98. KIVISTO KT; NEUVONEN PJ
      ACTIVATED-CHARCOAL FOR CHLOROQUINE POISONING

      BMJ. British medical journal
    99. KIVISTO KT; LEHTO P; NEUVONEN PJ
      THE EFFECTS OF DIFFERENT DOSES OF SODIUM-BICARBONATE ON THE ABSORPTION AND ACTIVITY OF NON-MICRONIZED GLIBENCLAMIDE

      International journal of clinical pharmacology, therapy and toxicology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 20:48:52